Madrigal Letterhead]Indemnification Agreement • July 22nd, 2016 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJuly 22nd, 2016 Company Industry JurisdictionFollowing the execution of the Merger Agreement and prior to the Trigger Date, as defined below (the “Effective Date”), you will devote 50% of your working attention serving in an interim role serving as President reporting to the Board of Directors of Madrigal (the “Board”). Following the satisfaction of all conditions precedent to closing the Merger under the Merger Agreement, for which Madrigal agrees to give you prompt written notice at the email address listed above, and immediately prior to the effective date of the Merger (collectively, the “Trigger Date”), you will serve as full-time Chief Executive Officer of Madrigal, reporting to the Board. Effective as of the Trigger Date, you will be elected by the Board as Chairman of the Board.
Madrigal Letterhead]Indemnification Agreement • July 22nd, 2016 • Synta Pharmaceuticals Corp • Pharmaceutical preparations • Pennsylvania
Contract Type FiledJuly 22nd, 2016 Company Industry JurisdictionOn behalf of Madrigal Pharmaceuticals, Inc. and its affiliates and successors (collectively, “Madrigal”), and in anticipation of the closing of issuance of convertible senior notes of Madrigal and certain transactions contemplated under the Amended and Restated Senior Note Purchase Agreement of even date (the “Agreement”), I am pleased to confirm our offer to you of the following compensation package, subject to the terms and conditions outlined in this letter agreement (this “Letter Agreement”). Capitalized terms not defined in this Letter Agreement shall have the meanings set forth in the Agreement. The terms of your employment will be as follows: